LONDON, Feb. 13 -- The government of the United Kingdom issued the following news:
The pioneering Yellow Card Biobank, a pilot launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, will today start investigating a new group of medicines used to prevent strokes known as Direct Oral Anticoagulants.
The Yellow Card Biobank aims to help understand how a patient's genetic makeup can impact the safety of their medicines and forms part of a long-term vision for more personalised medicine approaches. Approved scientists will use the genetic information in the Biobank to investigate whether a side effect from a medicine was caused by a specific genetic trait. This would in turn enable healthcare professio...